New anticancer drugs from marine cyanobacteria

Patrizia Russo, Alfredo Cesario

Research output: Contribution to journalArticlepeer-review


Marine Cyanobacteria have raised growing attention as sources of bioactive "secondary metabolites" that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.

Original languageEnglish
Pages (from-to)1048-1053
Number of pages6
JournalCurrent Drug Targets
Issue number8
Publication statusPublished - Jul 2012


  • Apratoxins
  • Bisebromoamide
  • Coibamide
  • Largazole
  • Lyngbya
  • Symploca

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine


Dive into the research topics of 'New anticancer drugs from marine cyanobacteria'. Together they form a unique fingerprint.

Cite this